Efficacy of increased-dose erlotinib for central nervous system metastases in non-small cell lung cancer patients with epidermal growth factor receptor mutation

PURPOSE: Recent reports indicate that refractory central nervous system (CNS) metastases of non-small cell lung cancer (NSCLC) are improved by high-dose gefitinib or erlotinib administration. We describe a Japanese woman with NSCLC and CNS metastases who was resistant to 75 mg daily erlotinib, but t...

Descripción completa

Detalles Bibliográficos
Autores principales: Togashi, Yosuke, Masago, Katsuhiro, Fukudo, Masahide, Tsuchido, Yasuhiro, Okuda, Chiyuki, Kim, Young Hak, Ikemi, Yasuaki, Sakamori, Yuichi, Mio, Tadashi, Katsura, Toshiya, Mishima, Michiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180562/
https://www.ncbi.nlm.nih.gov/pubmed/21681573
http://dx.doi.org/10.1007/s00280-011-1691-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180562/
https://www.ncbi.nlm.nih.gov/pubmed/21681573
http://dx.doi.org/10.1007/s00280-011-1691-z

Ejemplares similares